Covered Call Analyzer Aggressive "STOCKS-TO-CONSIDER"     

  for October, 2003                                                                                    Close Window

Company Name

Stock Symbol

Stock Price

# of shares

Total Cost*

 Option Symbol

 Nov Option Price

Income from sale*

Strike Price

Projected return if Called after one month*

Actual 

$ 

return*

Actual 

% 

Return*
USG Corp. USG $17.47 500 $8,755 USGKX $0.95 $455 22.5 28% +$810 +9%
Comments:

Not called. Sold Dec17.5 at 0.55. Not Called. Sold Jan17.5 at 0.25. Called.
CV Theraputics CVTX $18.00 500 $9,020 UXCKX $1.20 $580 22.5 26% ($50) -1%
Comments:

Not called. Sold Dec20 at 1.90. Exercised get-out price at $15.30 after buying back calls at 0.38. 
USG Corp. USG $17.47 500 $8,755 USGKD $1.60 $780 20 19% +$1,135 +13%
Comments:

Not called. Sold Dec17.5 at 0.55. Not called. Sold Jan17.5 at 0.25. Called.
Hollis-Eden Pharm. HEPH $17.15 500 $8,595 QGQKD $1.05 $505 20 18% ($985) -11%
Comments:

Exercised get-out price at $14.57 after buying back calls at 0.36. 
Oxigene, Inc. OXGN $10.95 900 $9,875 QYOKV $0.65 $565 12.5 16% ($524) -5%
Comments:

Not called. Sold all shares at $9.74 to close out position.
Genesis Microchip GNSS $16.01 600 $9,626 QFEKW $1.15 $670 17.5 13% +$1,544 +13%
Comments:

Called.
American Pharm APPX $27.37 300 $8,231 AQOKF $1.80 $520 30 13% +$1,289 +13%
Comments:

Called.
AMR Corp. AMR $13.93 700 $9,771 AMRKC $0.75 $505 15 10% ($524) -5%
Comments:

Not called. Sold all shares at $12.46 to close out position.
ZORAN Corp. ZRAN $18.85 500 $9,445 ZUOKD $1.00 $480 20 9% ($855) -9%
Comments:

Not called. Sold all shares at $16.18 to close out position.
CV Theraputics CVTX $18.00 500 $8,020 UXCKD $1.85 $905 20 17% +$275 -3%
Comments:

Not called. Sold Dec20 at 1.90.  Exercised get-out price at $15.30 after buying back calls at 0.38. 

All positions closed out with value up +$4,006.

*After the effect of all commissions.

The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.

top